CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Safe Environment
(Tag F0584)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation and interview, during the Recertification Survey, the facility did not ensure that housekeeping and mainten...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation and interview, during the Recertification Survey, the facility did not ensure that housekeeping and maintenance services were maintained. Specifically, wheelchairs were observed layered with an accumulation of dirt, dust and debris for 4 residents (Residents # 77; # 140; #109 and # 114). This was evident for 1 of 8 resident units observed for the Environment (Unit 2).
The findings are:
The facility policy titled Wheel Chair Cleaning dated March 2018 documented: It is the policy of [NAME] Care Center to ensure that residents' wheel chairs and walkers are cleaned on a regular basis. Depending on number of wheel chairs used on each unit, approximately two units are scheduled per week, each wheel chair is to be cleaned on a monthly basis.
1.) On 05/10/19 at 10:05 AM, the wheelchair of Resident # 77 was observed with an accumulation of dirt, dust and debris while in the dining room area.
2.) On 05/10/19 at 10:05 AM, the wheelchair for Resident #140 was observed with an accumulation of dirt, dust and debris, while in the dining room area.
3.) On 05/10/19 at 10:08 AM, the wheelchair for Resident #109 was observed with an accumulation of dirt, dust and debris while in the dining room area.
4.) On 05/10/19 at 10:10 AM, the seat cushion and wheelchair of Resident #114 was observed with an accumulation of of crumbs, dust, dirt and debris, while sitting in the dining room area.
A review of the Wheel Chair, schedule for May, 2019 found discrepancies between the actual wheel chair schedule and the actual Wheel chair Cleaning Form.
On 05/10/19 at 10:14 AM the 2nd floor unit Housekeeper was interviewed. The Housekeeper stated that wheelchairs are washed at night from 10: 00 PM - 6:00 AM by an assigned housekeeping staff member. The Housekeeper further stated they should also be noticing if wheelchairs are in need of immediate cleaning.
The Director of Environmental Services was interviewed at 10:20 AM on 05/10/19. She stated that she is responsible for ensuring the visitors , staff, and residents have a safe, clean, and comfortable environment. She further stated that each morning, environmental rounds done to observe staffs' work which includes environmental cleanliness, elimination of odors, and wheelchair maintenance. The Housekeeping staff and each unit are provided with a monthly wheelchair cleaning schedule. The DES stated she has a housekeeping staff member from 10:00 PM - 6:00 AM whose duties include the power washing washing of wheelchairs. If a wheelchair needs immediate attention for cleaning, the nurse on the unit can notify her. The Housekeeping staff should be reporting wheelchairs that require immediate washing. She could not verify the number of wheelchairs on each unit.
415.5(h)(2)
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Assessment Accuracy
(Tag F0641)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, record review, and interview, during the Recertification survey, the facility did not ensure that the asse...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, record review, and interview, during the Recertification survey, the facility did not ensure that the assessment accurately reflected the resident's status. Specifically, 1.) Residents with Hemodialysis, oxygen use, and inplanted defibrillator were not captured on the Minimum Data Sets (MDS) assessments. 2.) A resident who was not in use of a Ventilator was coded as receiving Ventilator ttreatment while in the facility. This was evident for 2 of 38 residents reviewed for MDS Assessment (Resident #167 and 275).
The findings are:
1) Resident #167 was re-admitted [DATE] with diagnoses which include Heart Failure, Diabetes Mellitus Hypernatremia, and End Stage Renal Disease.
On 05/07/19 at 11:39 AM resident #167 was observed in room sitting on the bed. An arteriovenus (AV) fistula was noted on the left hand of the resident. The resident stated he has been on dialysis for about 7 years, and goes for dialysis 3 times a week on Tuesday, Thursday and Saturday.
The Quarterly Minimum Data Set 3.0 (MDS) assessment, Reference Date (ARD) 3/8/2019, documented that the resident was re-admitted [DATE], with diagnoses which include Heart Failure, Hypertension, Pneumonia, diabetes Mellitus, Hypernatremia, Hyperlipidemia, Anxiety, Asthma. The MDS documented the resident requires supervision with 1 person assist for bed mobility, transfer, Locomotion, toilet use and personal hygiene.
The MDS did not include hemodialysis among the specialized treatments received by the resident.
The Comprehensive Care Plan (CCP) for Dialysis, created on 3/16/17, documented that the resident is at risk for complications related to Hemodialysis access site. The CCP was revised on 6/4/18, with the goal that the resident will remain free of redness, swelling, excessive bleeding, drainage, tenderness to access site. On 7/26/2018, the CCP was updated. Interventions included: Resident will have to go snacks to go on dialysis days; Visually observe shunt site after dialysis for redness, swelling, excessive bleeding, drainage, tenderness to access site; Check bruit and thrill s/p dialysis.
The Physician's order, revision date 3/17/2019, documented: Consult: Queens Dialysis center every T/TH/SAT; Check left arm AV fistula for bleeding, bruit and thrill every shift and alert MD for complication; No BP or Blood work to the left arm.
On 05/10/19 at 10:30 AM, the MDS Coordinator (MDSC) was interviewed. The MDSC stated that in order to complete the MDS assessment, she reviews Physician's orders, speaks with the staff on different shifts, and observes the residents to corroborate the information. She also stated that every month she checks to see if every area is captured, but she did not understand why the error noticed on the current MDS was not captured. She stated that she is aware that the resident is on dialysis, but it could have been the error of the assessor. The MDS coordinator further stated that immediate action will be taken to correct the situation
2) Resident #275 was admitted to the facility on [DATE] with diagnoses which include Hypertension, Diabetes Mellitus, Heart Failure, and Automatic Implanted Defibrillator.
On 05/08/19 at 11:17 AM, the resident was observed in the room, sitting on a wheel chair, alert and awake. The resident was interviewed about care received. An oxygen tank and a cardiac monitoring machine were observed bedside.
On 05/10/19, a review of the MDS assessment dated [DATE] documented the resident had intact cognition. The MDS further documented the resident had diagnoses of Hypertension, Diabetes Mellitus, Heart Failure, and End Stage Renal Disease. The MDS documented the resident received specialized treatments of Hemodialysis and ventilator while a resident.
Furthermore, there was no indication on the MDS that the resident receiving oxygen treatment and no indication that the resident had an implanted defibrillator.
A review of the resident admission record dated 02/18/15 documented that the resident has a diagnosis of Automatic Implantable Cardiac Defibrillator.
A review of current May 2019 Physician's order documented the following: Oxygen 2 Liter per minutes via nasal Canula as needed. The order was initiated 4/10/19.
There was no documented evidence in the medical record that the resident was ever on a ventilator. The MDS assessment also did not include oxygen therapy under treatments received by the resident.
On 05/10/19 at 12:10 PM, an interview was conducted with the MDS Director. She stated that she had been doing the MDS since 2102, and she is responsible for accuracy of the MDS assessment. She stated that the resident was never on ventilator at this facility. She acknowledged coding resident # 275 as a ventilator resident was an error. The MDS director also stated that, a resident with the use of intermittent or continuous use of oxygen must be coded on the MDS.
415.11(b)
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Comprehensive Care Plan
(Tag F0656)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record reviews and staff interviews conducted during the recertification survey, the facility did not ensure the develo...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record reviews and staff interviews conducted during the recertification survey, the facility did not ensure the development and implementation of comprehensive person-centered care plans for each resident, consistent with the resident rights that includes measurable objectives and time frames to meet residents medical, nursing, and mental and psychosocial needs that are identified in the comprehensive assessment. Specifically, a comprehensive care plan was not developed for a resident who was admitted with a cardiac monitoring machine. This was evident for 1 of 38 sampled residents (Resident # 275).
The finding is:
A facility Policy and Procedure related to Resident Care Planning dated April 2016 documents that the facility will develop individualized comprehensive care plan which include measurable goals, and timely meet the resident's medical, nursing, mental and psychosocial needs of each resident. The Care plan further documented that Comprehensive care plans is developed with 7 days of the completion of the resident comprehensive assessment.
Resident #275 was admitted to the facility on [DATE]. As per the admission record dated 02/18/15 documented that the resident was admitted with the following diagnoses which include Hypertension, Diabetes Mellitus, Heart Failure, Automatic Implanted Defibrillator, and End Stage Renal Disease.
On 05/08/19 at 11:17 AM, the resident was observed in the room, sitting on a wheel chair, alert and awake. During the resident interview, the resident stated that he goes to dialysis three times a week, and has been on hemodialysis treatment for few years. Resident was also observed with oxygen tank near bedside, and a cardiac monitoring device (Boston Scientific cardiac monitoring machine) was also observed at the bedside table. The resident stated that the machine was given to him a few years ago, and it transmits his heart rates to his cardiologist. If there is a problem, they will contact me or the nursing home.
On 5/10/19, a review of the resident admission record dated 02/18/15 documented that the resident has a diagnoses of Automatic Implantable Cardiac Defibrillator.
A review of Physician order dated 5/01/19 documented the following: Boston Scientific cardiac monitoring machine to be plugged at all time.
The comprehensive care plan did not reflect the cardiac monitoring machine or include interventions regarding care or monitoring required for the machine.
On 05/10/19 at 11AM, an interview conducted with the Register Nurse Manager (RN #3). The RN stated that the staff are aware that the resident has a implanted defibrillator and cardiac monitoring machine that has to be plugged in at all times. RN #3 further stated that she started working here in February 2019, and she is responsible for care plaining. She further stated that the resident had a cardiac care plan, but the use of the cardiac monitoring machine was not included. She stated that I think we missed it.
415.11(c)(1)
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Pressure Ulcer Prevention
(Tag F0686)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observations interview and record review during a Recertification Survey, the facility did not ensure that a resident w...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observations interview and record review during a Recertification Survey, the facility did not ensure that a resident with a pressure ulcer, receive the necessary treatment and services, consistent with professional standards of practice, to promote healing, prevent infection and prevent new ulcers from developing. Specifically, a pressure relieving device for a resident with foot/leg ulcer was missing and observed not in place. This was evident for 1 of 3 Residents reviewed for Pressure Ulcer Care (Resident # 293).
The finding is:
Resident # 293 was admitted on [DATE] with diagnoses which include Venous/ Arterial Ulcers and Cellulitis (bacterial skin infection) to lower extremity.
The initial Minimum Data Set 3.0 (MDS) assessment dated [DATE], documented the resident had intact cognition and required extensive staff assistance for activities of daily living (ADL) needs. The MDS further documented the resident was admitted with Stage 2 and Stage 3 pressure ulcers.
On 05/07/19 at 10:20 AM, Resident #293 was observed while in bed with her right leg resting on one pillow. A wound dressing was observed on her right lower leg, exposing her toes which appeared red and swollen. The resident was awake and alert. The resident stated that for five days, she has been missing her heel booties. She stated that a few days ago, a staff member told her the booties were sent to the laundry. She continued to say that she has to place a pillow herself to provide pressure relief for her right foot, and since she already has a heel pressure ulcer, she is concerned about developing more or making it worse. She stated that the heel booties provide her with comfort and relieve her from worry. They make a difference.
On 05/08/19 at 8:05 AM, the resident was observed in bed, asleep. The resident was not wearing heel booties at this time. Her right leg was resting on a pillow. A right lower leg dressing was observed, and a stocking was observed on her right foot, exposing her toes.
On 05/09/19 07:43 AM, the resident was observed while in bed. Heel booties were observed in place to both feet. The resident stated that she was relieved to have them on, and the staff just provided them to her. She stated that she feels better with the booties on while in bed, and not as concerned about the heel pressure ulcer with the booties in place.
The Comprehensive Care Plan initiated on 02/20/19 (CCP) for Pressure Ulcer documented, impaired skin integrity as evidenced by stage 3 ulcer present. At risk for deterioration. Interventions included use of lower extremity pressure reducing device to bed.
Review of the CNA Accountability record (Profile History Report) dated 02/26/19 documented, apply heel bootie while in bed.
Wound Care Note dated 05/10/19 documented foot wound right heel, off load pressure on area.
On 05/09/19 at 12:00 PM, the Certified Nurse Aide (CNA) assigned was interviewed. She stated that the resident requires extensive assist of one person. The resident has a pressure ulcer on her foot and should be wearing protectors while in bed, to relieve pressure on the heel. She stated that the heel booties were sent to the laundry on Thursday, May 2nd, and should have returned the following day, May 3rd. The CNA stated that she worked the weekend on May 4th and 5th. She stated that she checked the laundry room for the booties and found none. She stated that she did not report this to her nurse.
On 05/09/19 at 12:14 PM, the Registered Nurse Unit Manager (RNM) was interviewed. She stated that she was the person who provided the Resident with a new pair of booties. The RNM stated that she requested a pair from the housekeeping department. She stated that she was not made aware that the resident needed booties before now. The Aides should be reporting these issues, and the CNA accountability record documents that the booties should be in place. Off-loading pressure on pressure ulcers is a treatment provided by nursing. This intervention is on the CNA accountability record because it should be a part of the resident's care.
On 05/13/19 at 07:35 AM, the State Agency (AS) attempted to observe the wound care treatment as scheduled, however, the treatment had already been completed by the night shift nurse.
415.12(3)(c)(1)
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0697
(Tag F0697)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview and record review conducted during a recertification survey, the facility did not ensure that pa...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview and record review conducted during a recertification survey, the facility did not ensure that pain management was provided to a resident who required such services, consistent with professional standards of practice, the comprehensive person-centered care plan, and the resident's goals and preferences. Specifically, the Licensed Practical Nurse (LPN) did not administer prescribed pain medication to a resident prior to a wound dressing change. This was evident for 1 of 3 residents reviewed for pressure ulcer care. (Resident # 284).
The finding is:
Resident # 284 was admitted to the facility on [DATE] with diagnoses which include: Hypertension, Failure to Thrive, and Pressure Ulcers on Back, Buttock, and Hip.
On 5/13/19 at 7:10AM, the resident was observed in the room sitting in the Geri-Chair. The resident was alert and awake but unable to make conversation.
On 5/13/19 at approximately at 7: 00AM , upon arrival of the State Agency Representative to the unit, the night Licensed Practical Nurse (LPN # 1) stated that she had performed the wound care for resident #284 at 6:00AM. When asked LPN # 1 if she was aware that the wound was scheduled to be observed today at 7:00 AM, she stated that she was never aware. The LPN further stated that she has been working here for the past 5 years as an LPN, she works 11 PM to 7AM, 5 days a week. She stated that the wound is not scheduled on her shift. She stated the wound changed today because the night CNA was doing the AM care. She stated the wound is scheduled for the day nurse, but she was told by the night supervisor to change the wound at 6:30 AM.
The Physician's order dated 04/09/19 documented the following wound care order: Left Gluteus: Cleanse area with NSS. Pat dry. Apply Mupirocin Ointment, cover with Calcium Alginate & Foam Dressing one time a day for wound healing related to Pressure Ulcer. The orders further documented the resident should receive Tylenol Tablet 325 MG (Acetaminophen)- 2 tablest via G-Tube every day and evening shift and 30 minutes prior dressing change for Pain.
On 05/13/19 at 7: 22 AM, a review of Medication Administration Record documented that the resident did not receive the order of Tylenol Tablet 325 MG (Acetaminophen)- 2 tablets via G-Tube prior to the dressing change on 5/13/19 at 6:00 AM.
On 05/13/19 at 7: 22 AM, LPN # 1 was interviewed. She stated that she never administered the pain medication to the resident prior to wound dressing change. She stated that the resident does not receive early medication like Synthroid. She also stated that resident # 284 only receives medication during the 7 to 3 shift. The MAR was reviewed with the LPN # 1 who acknowledged that Tylenol Tablet 325 MG 2 tablet via G-Tube 30 minutes prior dressing change was never administered.
On 05/13/19 at 07:38 AM, an interview conducted with LPN #2 who she stated that she has been working here for 4 years, she works 7 to 3pm, 5 days per week. LPN # 2 stated that the wound is usually changed between 7 and 10 AM, and that she was aware that the State Agency Representative was coming to observe the wound at 7am and she was ready to perform wound care. LPN # 2 stated she was surprised to hear that the wound had been changed.
On 05/13/19 at 11:32 AM, an interview conducted with the DNS who stated that she spoke with all supervisors in the evening to inform them that the State Agency Representatives are coming to observe the wound at 7:00 AM ON 5/13/19. The DNS could not explain why the wound dressing was changed at 6 AM
415.12
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Food Safety
(Tag F0812)
Could have caused harm · This affected 1 resident
Based on observation and interview, during the Recertification Survey, the facility did not ensure that food was served in accordance with professional standards for food service safety. Specifically,...
Read full inspector narrative →
Based on observation and interview, during the Recertification Survey, the facility did not ensure that food was served in accordance with professional standards for food service safety. Specifically, during a lunch meal observation, the Certified Nurse Aide (CNA) was observed using her bare hands to remove a bread roll from the cellophane bag and placed the bread on the resident's plate. This was evident for 1 of 8 resident floors observed for the Dining Observation task (4th floor).
The finding is:
On 05/07/19 at 12:05 PM, during a lunch meal observation on the 4th floor, the CNA was observed assisting Resident #160 with setting up their lunch. The CNA used her bare hands to remove a bread roll from the cellophane bag and placed the bread on the resident's plate.
On 05/09/19 at 7:54 AM, the CNA was interviewed. The CNA stated that food should not to be touched with bare hands because it is an infection control issue. She stated that she has been in-serviced on how to handle food, and she should have used a barrier when handling the bread. She further stated that she was not thinking.
The Unit Registered Nurse Manager (RNM) was interviewed on 05/09/19 at 12:05 PM. She stated that staff have in-services on how to handle food, and handling food with bare hands is not the facility practice. The RNM stated that she observes meal times to ensure staff are handling food properly.
415.14(h)
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0657
(Tag F0657)
Could have caused harm · This affected multiple residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY**
3) Resident #198 was admitted from an acute hospital on [DATE] with diagnosis which includes Falls, Rhabdomyolysis, and Hepatit...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY**
3) Resident #198 was admitted from an acute hospital on [DATE] with diagnosis which includes Falls, Rhabdomyolysis, and Hepatitis C.
The Quarterly Minimum Data Set (MDS), Assessment Reference Date (ARD) 4/15/2019 documented that resident has severe impairment in cognition with current diagnosis of Hypertension, Diabetes Mellitus, Hyperlipidemia, Non-Alzheimer's Dementia, Depression, Psychotic disorder. The MDS also documented the resident is on Antipsychotic and Antidepressant medications, and that Antipsychotics were received on a routine basis only; No gradual dose reduction (GDR) had been attempted. There was no documentation that the Physician documented a GDR was clinically contraindicated.
The Comprehensive care Plan on Psych meds updated 4/6/2019 documented: The resident uses psychotropic medications (Trazodone & Risperdal) r/t behavior management, disease process. Also documented that 3/23/19 - Remeron d/c due to weight gain and Trazodone started
The Physician's order with revision date 4/12/2019 documented: Trazodone HCI tablet 50mg at bedtime for depressive disorder. Risperidone 0.5mg PO 2 times daily for Unspecified Psychosis.
Comprehensive Care Plan on behavior dated 1/1/16 documented Alteration in Mood/Behavior secondary to mood disorder with the goal Resident will demonstrate use of effective coping strategies, and with interventions Determine cause of behavior; Administer medications as ordered by MD; Observe for side effect of medications; Redirect negative behavior; Maintain a calm environment; Psych consult as ordered by MD.
The Comprehensive Care Plan on Alteration in Mood/Behavior noted on chart was initiated 01/01/2016. There was no documented evidence that the CCP was reviewed or updated since it was created.
On 05/09/19 at 11:47 AM, an interview was conducted with the Unit Manager/Registered Nurse (RN#1).The RN stated that she has been working in the facility for about 2 months. RN #1 stated that as per record, resident was admitted with diagnosis of Major depressive disorder, unspecified dementia without behavior disturbance, unspecified psychosis not due to substance, unknown physiological condition, Opioid dependence and relentlessness and agitation. RN #1 stated that the resident has not been noted with any significant change in diet or behavior since her employment in the facility. The RN stated that the care plans are updated if there is any significant change in resident's condition/behavior, and if there is a note or report from any discipline, the care plan is updated to reflect the change. Care plans are also updated quarterly during quarterly assessment if there is no episodic issue during the period. RN #1 stated that there is no specific care plan for resident behavior other than the the one for Alteration in mood. The last update was 1/1/16. She could not say why the CCP was not updated because she has been employed in the facility since March 2019.
415.11(c)(2)(i-iii)
Based on observations, record review, and staff interviews conducted during the recertification survey, the facility did not ensure that the Comprehensive Care Plan (CCP) was reviewed after each assessment or revised with changes in the resident's needs. Specifically, (1) a resident at risk for victimizing other residents, did not have their CCP revised to reflect the current interventions to address this risk (Resident #46); (2) a resident's CCP was not reviewed and revised to reflect the resident's behavior improvement (Resident #97); (3) a resident's CCP for Mood/Behavior was not reviewed/revised after the quarterly assessment (Resident #198). This was evident for 3 of 5 residents reviewed for Unnecessary Medications out of a total sample of 38 residents (Resident #s 46, 97, and 198).
The findings are:
1) A facility Policy and Procedure related to Resident Care Planning dated April 2016 documents that the comprehensive care plan/Assessments of Residents are revised as information about the resident and the Resident's condition change. The Care Plan/interdisciplinary team is responsible for the review and updating of care plans.
Resident #46 was admitted to the facility 10/06/17 with diagnoses which include: Major Depressive Disorder, Recurrent, Vascular Dementia with Behavioral Disturbance, Other Symptoms & Signs Involving Emotional State, and Other Specific Personality Disorders.
The resident's most recent Quarterly MDS dated [DATE] documented the resident had received an antipsychotic medication 7 out of 7 days prior to the assessment being completed. Resident #15 also received antipsychotic medication on a routine basis and no Gradual Dose Reduction (GDR) was attempted. Diagnoses of Psychotic Disorder (other than Schizophrenia) and Major Depressive Disorder were not documented on the MDS. In addition, the resident was documented as having no hallucinations or delusions, did not exhibit any behavioral symptoms towards others 4-6 days within the past 2 weeks and wandered daily.
The Comprehensive Care Plan (CCP) focusing on Alteration in Mood/Behavior was initiated 1/19/18. The resident was documented as having an actual behavior problem as evidenced by being physically abusive (specify: slap roommate on face) secondary to behavior problems and impaired cognitive function. The CCP documented staff members observed the resident moving his bed around to different sides of his room, with the door closed and locking it with his bed. The staff were unable to go into the room and give care, despite encouragement. The resident refused to open door on 4/30/19. The CCP further documented that the interventions to address the Resident's mood/behavior include: redirect negative behavior, ongoing assessment of behaviors, administer medications as ordered, observe for side effects of medications, offer rest periods/quiet times, maintain a calm environment
A CCP focusing on resident at risk to victimize others was initiated 12/28/17. The CCP documented that Resident #46 attempted physical aggression (grab at or towards another resident) and attempted to follow staff (becoming belligerent, shouting/pointing finger at staff when redirected). The resident was transferred from the 6th floor to the 2nd floor on 4/26/2019. The CCP further documented that the interventions in place to address the resident's mood/behavior include: Referred to social service for further counseling, Psychiatry consult secondary to physical aggressive/restlessness.
Review of the Nursing Notes dated 12/1/2018 to 5/01/2019 documented that Resident #46 continues to be disruptive to other residents and staff member. The resident is redirected by staff but becomes physically aggressive towards them when redirected.
A review of the Medical Doctor (MD) and Nurse Practitioner (NP) notes from 2/1/19 to 3/28/19 did not reveal any documentation that the resident was having any hallucinations or had any behavior related to a diagnosis of Schizophrenia.
The CCP related to Resident #46 being at risk for abuse/victimization was not reviewed and revised with evaluations and new interventions to address the fact that the current interventions to prevent the resident from grabbing other residents were ineffective.
The CCP was not reviewed and revised with new interventions when the current interventions for discouraging Resident #46 from moving his bed around and locking the door with his bed therefore were not effective.
On 05/10/19 12:27 PM, an interview was conducted with the Registered Nurse Unit Manager (RN#3). The unit Manager stated that resident was transferred to her floor from the 6th floor on 4/26/19 after a resident-to-resident altercation. The resident has not had any altercations since he was transferred to the floor, but he does have behaviors. She further stated the resident has major depressive disorder, other specific personality disorders,and vascular disorder with major disturbance. The resident was seen by psychiatry for a review of medication s/p (status post) altercation on 4/15/19. The resident had multiple altercations on the previous floor. The psychiatrist recommended continuing the current dose of meds and supportive treatment for cognitive impairment and psychiatry follow-up as needed. She stated the resident displayed behaviors three times where staff reported that he would move the bed behind the door to prevent anybody, most likely other residents, from coming into his room. The RN further stated they got him a Spanish language board so that they can communicate with him to answer his requests, and they call the family to request visits. The RN stated the Recreation Department came to speak with resident in Spanish with language dialogue and board provided to counsel him for reassurance. She stated staff asked him why he was doing what he was doing, and the behavior stopped with the last incident on 5/1/19. The social worker, recreation department and nursing intervened, and, since then, there have been no behaviors. She stated they continue monitoring. The resident participates in unit floor activities since the transfers, and he is doing much better. He also watches television in his room as well. Unit Manager stated that she is responsible for creating, revising, and updating all care plans on the unit. She stated that the responsibility is shared between the night supervisors and unit managers. The Unit Manager stated that she was told that the CCP had to be updated every 90 days.
2) The facility policy and procedure on Care Plan was revised on April 2016 stated that the care planning/interdisciplinary team is responsible for the review and updating of care plans: when there has been a significant change in the resident's condition. When the desire outcome is not met. When the resident has been readmitted to the facility from a hospital stay and at least quarterly.
Resident #97 is a resident admitted to the facility on [DATE] with diagnoses which include Psychotic Disorder, Anxiety, Restlessness and Agitation, Epilepsy and Recurrent Seizure, Alzheimer's Disease, Insomnia, Dementia.
The Quarterly Minimum Data Set 3.0 (MDS) assessment dated [DATE] documented the resident had severely impaired cognition.
The Comprehensive Care Plan (CCP) for impaired cognitive function/dementia or impaired thought process r/t Dementia, psychotropic drug care plan was created on 11/16/18 was never revised. The goal for the resident is to maintain current level of cognitive function and to be able to communicate basic needs on a daily basis.
The Physician's orders dated 4/8/19 documented that more recently resident's behavior is more manageable with less psychosis and mood symptoms. He has history of mood lability, agitation, combativeness, oppositional behavior, elevated anxiety with restlessness and wandering in and out of other rooms in an intrusive manner towards others.
There was no documented evidence that the CCP was reviewed and revised to address the resident's behavior improvement.
On 5/13/19 at 12:41 PM, an interview was conducted with the Registered Nurse (RN #4) who stated when there is a new problem, care plans are initiated right away so everybody could be on the same page. I was on vacation when the resident developed the rash. The nurse supervisor who was on duty did not create the care plan.
On 05/13/19 at 02:09 PM, an interview was conducted with the Director of Nursing
Who stated that CCP are updated quarterly and as needed. If there is no change, they will put no change, continue same plan of care in the progress note and update individual care plan that need to be updated. I understand what you are saying that even though there is no change, we will make sure we update the care plan and date it so everyone can see that the care plan was revised.
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Medication Errors
(Tag F0758)
Could have caused harm · This affected multiple residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 2) Resident #198 was admitted from an acute hospital on [DATE] with diagnoses which include Dementia, Falls, Rhabdomyolysis, Hyp...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 2) Resident #198 was admitted from an acute hospital on [DATE] with diagnoses which include Dementia, Falls, Rhabdomyolysis, Hypertension (HTN), Hepatitis C, and Diabetes Mellitus (DM).
The Quarterly Minimum Data Set (MDS), Assessment Reference Date (ARD) 4/15/2019, documented that resident had severely impaired cognition with current diagnoses of Hypertension, Diabetes Mellitus, Hyperlipidemia, Non-Alzheimer's Dementia, Depression, and Psychotic disorder. The MDS also documented that resident is on Antipsychotic and Antidepressant medications, and that Antipsychotics were received on a routine basis only. No gradual dose reduction (GDR) had been attempted, and there was no documentation that the Physician determined GDR was clinically contraindicated.
On 05/09/19 at 09:43 AM, the resident was observed sitting in a wheelchair (w/c) in the day room, taken to his room for an interview and stated that he cannot remember when he was admitted to the facility, unable to recall the date and time, but able to engage in simple discussion. Resident stated he does not know the name and type of the medication being given to him because he does not ask, stated that they give me injection, but I don't know what. Resident also stated, I was on methadone long time ago to control my mood, but they stopped giving it to me. Resident stated that he does not know why it was stopped.
The Psychiatry Consult dated 9/11/2015 documented the consult was requested for an evaluation of mental status and management. The consult documented that resident was admitted with a history of Methadone withdrawal, Hx (history) of falls, Dehydration, Rhabdomyolysis, DM, HTN, Hep C, and OA (Osteoarthritis). The resident was on a Methadone program. The consult also documented that the resident does not have a history of previous psychiatric treatment or hospitalization. There were no acute incidents reported, and the resident did not display episodes of aggressive behavior.
The re-admission Orders from the Acute Hospital dated 11/06/2015 documented that resident was on Risperidone (Risperdal) 0.25 mg (milligrams) PO (by mouth) Q8H (every 8 hours) PRN (as needed) for signs and symptoms of delirium/agitation.
Risperdal is an antipsychotic medication used to treat Schizophrenia, Bipolar Disorder, or irritability associated with autistic disorder. The FDA black box warning indicates that elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk for death. Risperdal is not approved for use in patients with dementia-related psychosis.
The facility submitted a record of psychotropic medications received by the resident. The record documented the resident received Risperdal 0.25 mg BID, upon readmission, from 11/10/15 to 11/17/15.
The Psychiatry Consult Reevaluation note dated 11/17/2015 documented that the resident was admitted with a history of chronic systolic heart failure, DM, HTN, HLD (Hyperlipidemia), Chronic Hep C, NPH (Normal Pressure Hydrocephalus), and Methadone dependence. The resident was recently hospitalized due to NPH and was s/p (status post) right ventriculoperitoneal shunt. The chart was reviewed, and updated information was obtained from the nursing staff. The staff reported the resident displayed episodes of aggressive behavior and irritability. The consult documented Recommendations: continue with Methadone; as discussed with RN staff to increase Risperdal to 0.5mg PO BID for his agitation and outburst.
The facility record of psychotropic medications received by the resident documented the resident received Risperdal 0.5 mg BID from 11/17/15 to present.
The Comprehensive Care Plan (CCP) on Psych meds updated 4/6/2019 documented: The resident uses psychotropic medications (Trazodone & Risperdal) r/t (related to) behavior management, disease process. The CCP documented that 3/23/19 - Remeron d/c (discontinued) due to weight gain and Trazodone started.
The Comprehensive Care Plan on behavior dated 1/1/16 documented Alteration in Mood/Behavior secondary to mood disorder with the goal Resident will demonstrate use of effective coping strategies, and with the interventions: Determine cause of behavior; Administer medications as ordered by MD; Observe for side effect of medications; Redirect negative behavior; Maintain a calm environment; Psych consult as ordered by MD.
There was no documented evidence in the medical record that the facility assessed the resident's behaviors and attempted to come up with person-centered non-pharmacological interventions besides redirection. There was no comprehensive care plan to address mood.
The Psychiatric Consult Follow up notes dated 4/26/2016 documented that the psychiatrist reviewed the chart and obtained and update from the nursing staff. The resident's behavior was unchanged and manageable. There were no outbursts since the resident was transferred to a new unit. The resident was confused and cognitively impaired. There were no overt vegetative signs and symptoms of depression, and the resident was not suicidal or homicidal. There was no overt AVH (Audial/ Visual Hallucinations) or acute psychosis. The resident had diagnoses of Anxiety Disorder NOS and Dementia. The psychiatrist recommended continuing Remeron 30 mg.
The facility record of psychotropic medications received by the resident documented the resident received Remeron 30 mg daily from 4/26/16 to 3/23/19.
The psychiatry note dated 4/26/16 recommends to continue the Remeron insinuating the resident was on Remeron prior to 4/26/16.
The Psychiatric Consult Follow up notes from 7/16/2016 to 3/23/2019 were reviewed. The notes documented that Chart reviewed and obtained update from nursing staff. No incident reported/ No acute changes reported. All notes recommended continuing the Risperidone 0.5 mg BID to avoid relapse of his psychosis. The consult dated 3/23/2019 recommended: Continue on Risperidone 0.5mg BID protocol to avoid relapse of his psychosis. Switch Remeron to Trazodone 100 mg Q HS (at bedtime) due to his increased weight recently.
The facility record of psychotropic medications received by the resident documented the resident received Trazodone 50 mg HS from 3/23/19 to present. The Remeron was discontinued on 3/23/19.
There was no documented evidence that the attending physician or psychiatrist evaluated the risks versus benefits for the resident to receive Risperdal despite the FDA black box warning. There was no documented evidence that a Gradual Dosage Reduction (GDR) was attempted for the Risperdal despite the fact that the staff reported to the psychiatrist that the resident had no changes in behavior. The resident was on Remeron for almost 3 years with no attempts at GDR despite no changes in symptoms or description of mood symptoms.
The Psychotropic Weekly Nurses Notes from 4/27/2016 to 12/21/2016 were reviewed. The notes documented repeatedly that resident Maintained on Risperidone 0.5mg for unspecified psychosis. Ramelteon 8mg for insomnia, and Methadone 35mg for opioid dependence. Resident verbally abusive at times .Uses foul language in Spanish. Attempts to redirect met with some success. Continue to monitor.
Psychotropic Weekly Nurses Note dated 12/28/2016 documented Maintained on Risperidone 0.5mg for unspecified psychosis. Ramelteon 8mg for insomnia, and Methadone 35mg for opioid dependence. As of 11/28 resident placed on Remeron 15mg for appetite/depression. Increase food intake noted. Resident verbally abusive at times, however for the past week resident has been more subdued. Uses foul language in Spanish. Attempts to redirect met with some success. Continue to monitor.
Psychotropic Weekly Nurses Note reviewed between 1/23/2017 and 5/10/2017 documented repeatedly that resident Maintained on Risperidone 0.5mg for unspecified psychosis. Ramelteon 8mg for insomnia, and Methadone 35mg for opioid dependence. Remeron 15mg for appetite/depression. Increase food intake noted. Resident verbally abusive at times, however for the past week resident has been more subdued. Uses foul language in Spanish. Attempts to redirect met with some success. Continue to monitor
There was no documentation in the medical record that described the details of the resident's behavior. There was no documented evidence that the staff attempted to look at the patterns or details regarding what triggered the yelling or cursing. There was no documented evidence in the behavior notes that the resident displayed symptoms of psychosis such as hallucinations or delusions. There was no documented evidence that the resident was evaluated for a Gradual Dosage Reduction (GDR) of Risperdal when there were no changes in the resident's behaviors from 4/27/16 to 5/10/17. The Dementia-related behaviors continued despite the Risperdal.
The Psychotropic Weekly Nurses Notes from 5/24/2017 to 8/2/2017 documented repeatedly that resident Maintained on Risperidone 0.5mg for unspecified psychosis, Ramelteon 8mg for insomnia, and Methadone 35mg for opioid dependence. Remeron 15mg for appetite/depression. Resident remains stable. No behavioral issues noted.
The Psychotropic Weekly Nurses Notes from 9/13/2017 to 3/20/2019 repeatedly documented resident's psychotropic medications (Trazodone 50mg PO for depression, Risperidone 0.5mg PO for psychosis), and documentation that No behavioral issues noted every week.
There was no documented evidence that the resident was evaluated for a Gradual Dosage Reduction (GDR) of Risperdal when the resident displayed no behavioral symptoms from 5/24/17 to 3/20/19.
The Medication Regimen Review (MRR) dated 11/20/2018 documented the following Consultant Pharmacist recommendations: Currently receiving Clonidine for treatment of hypertension. Also noted to be receiving antidepressant therapy. Please note that Clonidine has potential to induce/exacerbate depression. Please evaluate risk versus benefit of Clonidine and consider taper to discontinue Clonidine and monitor blood pressure, if appropriate. Physician response documented: Disagree, Cont. as ordered.
There was no documented evidence in the medical record that the physician explained the clinical rationale for continuing the Clonidine depsite the Pharmacist's recommendations.
The MRR dated 12/18/2018, Consultant Pharmacist recommendations documented: Currently receiving Ramelteon (Rozerem) at bedtime for Insomnia. Please evaluate current need, consider trial taper to PRN for 1 week then discontinue, if appropriate. Physician Response documented Disagree; Still c/o Insomnia. Continue meds. F/U Psych.
The MRR dated 3/20/2019, Consultant Pharmacist recommendations documented Currently receiving Risperidone 0.5mg twice daily for psychosis. No recent behavior problems noted. Please evaluate current dosing, consider trial taper to 0.5mg daily dosing, or document inability to do so. Physician Response documented Disagree, Psych consult.
There was no documented evidence in the medical record that the attending physician documented their clinical rationale for continuing the Risperdal despite the pharmacist's recommendations.
The current Physician's order with revision date 4/12/2019 documented: Trazodone HCI tablet 50mg at bedtime for depressive disorder (started 4/1/19). Risperidone 0.5mg PO 2 times daily for Unspecified Psychosis.
The Psychiatric Consult Follow up notes dated 4/19/2019 documented: Request by staff to follow up adjustment of medication. Chart reviewed and obtained update information from nursing staff. Discussed case with nursing supervisor of patient's dosages of Trazodone and he is currently on 50mg. No acute changes reported as he is at his current baseline. He will need to continue his current psychotropic medication protocol to avoid relapse.
On 05/09/19 at 11:20 AM, an interview was conducted with the Certified Nursing Assistant (CNA #1). The CNA stated that she has been working in the facility for the past 17 years and has been having the resident's assignment since the 1st of May this year. Resident is taken out of bed by the night staff and given the breakfast by the day tour. The resident is taken back to bed after lunch if noted to be sleeping or not feeling comfortable. The CNA stated also that resident has not displayed any behavior problem since she has been taking care of the resident.
On 05/09/19 at 11:47 AM, an interview was conducted with the Unit Manager/Registered Nurse (RN#1). RN stated that she has been working in the facility for about 2 months. The RN stated that as per record, resident was admitted with diagnoses of Major depressive disorder, unspecified dementia without behavior disturbance, unspecified psychosis not due to substance, unknown physiological condition, Opioid dependence, relentlessness and agitation. The resident is monitored and assessed daily to check if there is any behavior outburst or problem. If there are concerns, she checks the medication that may cause the problem, calls the doctor for what needs to be done, gives medication as per physician's order, and re-assesses for the effectiveness. The RN stated that relevant information regarding medication monitoring is usually discussed during the morning report where all departmental heads are in attendance. The physicians are notified of concerns via the communication book, or they may be called on phone if there is an emergency. Concerns are also documented in the daily shift report and in the progress notes. The RN stated that the resident has not been noted with any significant change in diet or behavior since her employment in the facility. The RN further stated that the resident is being followed up by the psychiatrist, but there has not been any gradual dose reduction.
On 05/10/19 at 09:12 AM, the Psychiatrist (MD #1) was interviewed and stated that the resident was seen last on 4/19/19 for a follow-up evaluation. MD #1 further stated: when resident first came in, he was reported to be agitated, with periods of outbursts. The resident was monitored almost weekly for over a period of time. The behavior became such that psychotropic meds were needed because the resident was on opioids and taking Methadone for a long period of time. The MD stated that after observing the resident for some time and receiving continuous reports from the nursing staff that the resident continued to be agitated during care, it was decided to start him on low dose of Risperidone. When asked about evaluating for GDR, MD #1 stated that it is an ongoing process and is not up to him. He relies on nursing and the CNAs to obtain information. He stated he is just a consultant the comes weekly or as needed. He sees the resident, listens to staff, and reviews their recommendations. The Psych MD stated that he is not included in the interdisciplinary team (IDT) meetings. He does not receive any written report of irregularities identified by the pharmacist. MD #1 also stated: It is a judgement call not to change anything at this time, but if nursing tells him to make the change he will do so. MD stated that it is not a high dose, and since the nursing said, don't change anything, I'm afraid to change because I think if I change it there may be problem.
On 05/10/19 at 12:21 PM, the Attending Physician (MD #2) was interviewed. MD #2 stated that he believes the resident was admitted with the behavior of psychosis diagnosed from the hospital. The resident was seen by the Psychiatrist who reported that resident has some depression and was started on the medication. MD #2 stated that other approaches attempted prior the use of psychotropic medication are redirection by the staff and whatever recreation is giving the residents with behavior. The attending MD stated that he thinks due to the behavior reported, the psychiatrist has to recommend medications so that the resident does not decompensate. MD #2 stated that as far as he can remember, the Psychiatrist said that if the medication is reduced, it might relapse the behavior. MD #2 further stated that he is included 24/7 in the IDT meetings for the resident. He received the report of irregularities identified during the MRR from pharmacy. The MD stated he responds to the recommendation noted by documenting he agrees or disagrees.
On 05/13/19 at 02:06 PM, the Pharmacist was interviewed. The Pharmacist stated that MRR is done once a month. The Pharmacist stated that the documentation is checked for the need and effectiveness of the PRN medications and psychotropic medications. The labs and diagnosis in the physician's order is also reviewed. The Pharmacist stated any potential chance to adjust or discontinue the medication is recommended where necessary. The Pharmacist also stated that report of any irregularities is immediately made available to the facility's Director of Nursing and the Physician in writing via Physician Referrals /Findings. The Registered Nurse on duty is also notified when the irregularity requires immediate action.
415.15(b) (2) (iii)
Based on observation, record reviews, and staff interviews during the Recertification Survey the facility did not ensure residents were from unnecessary antipsychotic medications. Specifically, residents with diagnoses of Dementia and no history of psychiatric diagnoses, were prescribed psychotropic drugs without an appropriate indication and adequate monitoring to treat dementia-related behaviors. In addition, there were no person-centered nonpharmacological interventions put into place to address the behaviors, and there was no attempt at gradual dosage reduction in the absence of behaviors. This was evident for 2 of 5 residents reviewed for Unnecessary Medications (Resident #77 and #198).
The findings are:
The facility Policy and Procedure related to Psychotropic Medications dated April 2016 documents that a Physician shall order psychoactive medications only to treat specific conditions. The policy further documents that the prescriber shall attempt gradual dose reductions, unless clinically contraindicated.
The policy also documented that the clinical staff will observed, document and report to the attending physician information regarding the effectiveness of any interventions, including antipsychotic.
FDA ALERT [6/16/2008]: FDA is notifying healthcare professionals that both conventional and atypical antipsychotics are associated with an increased risk of mortality in elderly patients treated for dementia related psychosis. In April 2005, FDA notified healthcare professionals that patients with dementia-related psychosis treated with atypical antipsychotic drugs are at an increased risk of death. Since issuing that notification, FDA has reviewed additional information that indicates the risk is also associated with conventional antipsychotics. Antipsychotics are not indicated for the treatment of dementia-related psychosis.
1) Resident #77 is a resident admitted on [DATE] with diagnosis that included Vascular Dementia with Behavior Disturbance (as per admission Record onset date 01/28/19) and Unspecified Psychosis (onset date 01/30/19) not due to a substance or known physiological condition.
The admission Minimum Data Set (MDS) Assessment Reference Date (ARD) of 02/02/19, documented the resident had no serious mental illness or intellectual disability, clear speech, was rarely understood, and rarely understands cognitive status severely impaired. No displayed behaviors of physical / verbal aggression nor rejection of care. The resident displayed no behaviors of physical / verbal aggression or rejection of care, and no psychosis. The MDS documented no behavioral symptoms that would impact the resident or others. The resident required extensive assistance for activities of daily living needs (ADL's) and a wheel chair for mobility. The resident was frequently incontinent of bladder and bowel. The resident's diagnoses included Non -Alzheimer Dementia and Sequelae of Cerebral Infarction. The MDS further documented that the resident received psychotropic's (AP) medications on a routine basis with no gradual dose reduction (GDR) due to being clinically contraindicated by physician.
On 05/09/19 at 9:35 - 10:00 AM the resident was observed sitting in his wheelchair, in the dining room area. The resident was calm, chin to chest, eyes closed, easily aroused. The resident was encouraged by staff to use crayon for coloring but was not interested. The resident was stood up from her wheelchair and was re-directed to sit. The resident remained standing for 2 minutes before sitting back down. The resident was not participating in the ongoing activities. The resident stood up from her wheelchair again for several seconds before sitting back down.
On 05/09/19 from 11:27 AM to 11: 35 AM the resident was observed in dining room with their head down chin to chest and eyes closed. The resident was easily aroused when her name was called by the State Agent (SA) who sat beside her. The resident was not interviewable with slurred, slow speech. The resident remained seated, calm, and quiet during this time. No attempts were made to stand up from her wheel chair.
Review of the Comprehensive Care Plan (CCP) for Antipsychotics Medication, dated 03/05/19 documented the use of seroquel,depokote, trazodone related to behavior management, disease process (psychosis). Further documentation on 03/05/19 for a gradual dose reduction (GDR) of zypreza which was discontinued, and seroquel was started. Interventions included medical doctor to consider dosage reduction when clinically appropriate; monitor side effects and adverse reaction.
The Hospital and Community and Community Patient Review Instrument (PRI) dated 01/23/19 documented the resident has no known history of verbal / physical aggression. The resident had no known history of disruptive, infantile or socially inappropriate behaviors and no hallucinations.
The Hospital Discharge Medication Information, dated 01/28/19 documented that Resident #77 received Zyprexa 6.25 milligrams (mg) at night by mouth, in addition to receiving Zyprexa 3.75 mg daily in the afternoon, and Zyprexa 2.5 mg in the morning for Vascular Dementia without behavioral disturbance. The resident received Divalproex Sodium (Depakote) for Vascular Dementia without behavior disturbance. Lacosamide (Vimpat)100 mg twice daily for Vascular Dementia with behavior with disturbance, unspecified dementia.
Zyprexa is an antipsychotic medication used to treat schizophrenia and acute manic episodes associated with bipolar disorder. The Food and Drug Administration (FDA) black box warning documents antipsychotics can cause an increased risk of death in elderly people who are confused, have memory loss, and have lost touch with reality (dementia-related psychosis). There is an increased risk of stroke or mini-strokes called Transient Ischemic Attacks (TIAs) in elderly people with dementia-related psychosis. Antipsychotics are not approved for use in these patients. Depakote is a drug used to treat manic episodes associated with bipolar, epilepsy and migraines. Vimpat is a controlled substance used for seizures.
Review of current list of medications for May, 2019 documented: On 01/29/19 the resident was started on Lacosamide 100 mg twice a day for Vascular Dementia without behavior disturbance. On 03/06/19 the resident was started on Trazadone 50 mg twice a day for Depressive Disorder. On 02/20/19 was started on Valproic Sodium Solution 250 mg /5 milliter (ml) daily for unspecified convulsions. On 03/06/19, Zypreza was stopped, and the resident was started on Seroquel 100 mg three times a day (morning, evening, night) for unspecified psychosis not due to a substance or known physiological condition.
Seroquel is an antipsychotic medication used to treat Schizophrenia and Bipolar Disorder. Seroquel is not approved for use in residents with dementia-related psychosis.
Review of the Behavior Notes: 02/07/19; 02/12/19; 02/27/19; 03/04/19; 03/20/19; 03/21/19 and 04/25/19 documented the following:
02/07/19: Resident continues to get out of bed despite education. Not easily redirected. combative towards staff. Close observation.
02/12/19: Resident with confusion at baseline. Out of bed (oob) in day room for status post (s/p) fall continues to display agitation /restless behavior, not easily redirected, behavior not altered by medication. Resident constantly tries to get up from chair to ambulate independently despite being ambulated, toileted and offered snacks and hydration. Emotional support/constant re-direction offered to no avail resident often requires 1:1 supervision for safety reasons.
02/27/19: Res. continues to try to get up from wheelchair (w/c), not easily re-directed.
03/04/19: Resident continues to get out of w/c and attempted to ambulate with an unsteady gait, not easily re-directed.
03/20/19: Resident continues to display behaviors, continues to get up from w/c, not easily re-directed, safety maintained.
03/21/19: Continues to get out of w/c, difficult to re-direct.
04/25/19: Resident combative /abusive towards others.
Review of the Individual Resident Participation Profile, dated 01/2019 for the months of January thru May 2019 found that the resident was identified exhibiting a behavior on just one (1) day in the month of April. Specifically on April, 8, 2019 this document was marked with a letter B indicating Behavior.
Review of psychiatric notes dated: 02/02/19; 03/05/19; 03/23/19; 03/29/19 and 05/04/19 documented the following:
02/02/19: 76 y/o female here for psychiatric evaluation of her mental status and management. Has a history of Vascular Dementia with behavior issues and agitation. On Zyprexa 5 miligram (mg) by mouth twice a day and 5 mg at bedtime for psychosis. Patient not able to provide history. There are no acute incidents reported recently but has not displayed any episodes of aggressive behavior nor irritability. Mood: labile with agitation, Affect: constricted.no paranoia, no suicidal ideation, no sign symptom of depression. Impression: psychosis NOS Recommendation: Treat underlying medical etiology adjust her Zyprexa to 5 mg po bid and 5 mg hs. monitor for side effects (s/e).
03/05/19: psychiatric visit documented that on 02/23/19 the medication was adjusted due to increasing agitation. Obtained updated information from nursing staff. Recently staff had expressed concern about her agitation and not sleeping. Patient has a history of behavioral issues and agitation and was prescribed Zyprexa for her psychosis. Recommend: discontinue Zyprexa and switch to Seroquel 100 mg by mouth twice a day and at bedtime for agitation and psychosis. Recommend: discontinue Zyprexa and switch to Seroquel 100 mg po bid and 100 mg po hs, for agitation and psychosis. Continue Depakene liquid 250 mg daily for mood swing. Continue Trazodone 50 mg twice a day.
03/09/19 Psychiatric follow up visit for agitation and erratic behavior. Chart reviewed and obtained update information from nursing staff. patient continues with Seroquel due to insomnia and out of control behavior. No adverse effects reported, more calmer and sleeping has improved. However, patient had been reported of escalation and increasing psychosis. No SI; no s/s depression. Recommend: Seroquel 100 mg po bid and 100 mg hs for agitation and psychosis. continue Depakene 250 mg daily for mood swings. Continue Trazodone 50 mg po twice a day.
03/23/19: Psychiatric follow up visit for agitation and erratic behavior. No paranoia, No depression. Continue medications and monitor.
03/29/19: Psychiatric follow up visit for agitation and erratic behavior. Continue with Seroquel due to insomnia and out of control behavior. Patient recently suffered a swollen hand. No acute findings. Patient will continue her medications to avoid relapse.
05/04/19 Psychiatric follow up visit documented increasing agitation and erratic behavior. Psychotropic Weekly Nurses Note from 05/01/19, documented that the resident often tries to get up from w/c, re-directed with some success. Continue medications to avoid relapse.
Review of the Primary Physician monthly notes dated 03/31/19 - 05/06/19 repeated documented the following: Dementia / psychosis; Continue with Seroquel; Continue with Trazodone. There is no documented evidence that her medications are being monitored for effectiveness. There is no documented evidence regarding what behaviors are being treated by the Seroquel, Depakene, and Lacosamide. There is no documentation by the physician regarding monitoring the resident's depression symptoms and evaluating whether the Trazodone is effective.
On 05/09/19 at 10:32 AM the assigned Certified Nurse Assistant (CNA) who stated that the resident is assigned to her for the whole month of May, 2019. The CNA stated that the resident is a nice person, does not give her any problems. She stated that the only thing about the resident is that she gets up from her chair a lot and is on fall precautions, and has to be careful with her. The CNA further stated that the resident is confused, is not a fighter and is not showing signs of aggression.
On 05/09/19 at 10:20 AM The unit Licensed Practical Nurse (LPN) was interviewed and she stated that she has not notices any behaviors except to say that the resident does get up a lot from her wheel chair and we just re-direct her back down. It is not always easy to re-direct her,as she remains standing and wants to try to walk. Someone is always around to keep her safe.
On 05/09/19 at 10:36 AM the Registered Nurse Manager (RNM) was interviewed and she stated the resident use to be combative at times during toileting, sundowning during the evening. The RNM stated that the resident's behavior has changed since February of this year and is now much calmer.
On 05/09/19 at 04:28 PM the primary physcian was interviewed. He stated that he is not a psychiatrist and leaves that part of the resident's care to them, as he is not a specialist in this area. He further stared that the resident does get up from her chair, but she does not have psychosis as far as he knows. He further stated that he reviews the hospital records and is aware that she entered the facility on psychotropic medications, which is why he referred the resident to the psychiatrist. He stated that the resident is not a danger to herself or others. He stated that she does get agitated and gets up often from her chair and it could be a danger to other residents and herself, although not yet.
On 05/10/19 at 08:51 AM, the psychiatrist was interviewed and he stated that he speaks to staff to get updates on his residents. He stated that the staff had reported to him that the resident is difficult to re-direct, and they asked him to help them because she was out of control and becomes aggressive and combative towards staff. The Psychiatrist stated he has not seen the resident agitated during his visits. He stated that he sees that she is calmer now, and they have a few months to determine if a reduction is warranted.